Silence Therapeutics Statistics
Total Valuation
SLNCF has a market cap or net worth of 148.29 million. The enterprise value is 1.07 million.
| Market Cap | 148.29M |
| Enterprise Value | 1.07M |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +24.69% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 22.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.43 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.02 |
| EV / Sales | 0.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.02 |
Financial Position
The company has a current ratio of 11.14, with a Debt / Equity ratio of 0.00.
| Current Ratio | 11.14 |
| Quick Ratio | 10.36 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -58.08% and return on invested capital (ROIC) is -39.61%.
| Return on Equity (ROE) | -58.08% |
| Return on Assets (ROA) | -19.24% |
| Return on Invested Capital (ROIC) | -39.61% |
| Return on Capital Employed (ROCE) | -26.68% |
| Revenue Per Employee | 372,914 |
| Profits Per Employee | -390,595 |
| Employee Count | 116 |
| Asset Turnover | 0.27 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.13% in the last 52 weeks. The beta is 1.25, so SLNCF's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -88.13% |
| 50-Day Moving Average | 1.28 |
| 200-Day Moving Average | 4.09 |
| Relative Strength Index (RSI) | 46.64 |
| Average Volume (20 Days) | 14,300 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.35 |
Income Statement
In the last 12 months, SLNCF had revenue of 43.26 million and -45.31 million in losses. Loss per share was -0.98.
| Revenue | 43.26M |
| Gross Profit | 31.45M |
| Operating Income | -49.58M |
| Pretax Income | -44.46M |
| Net Income | -45.31M |
| EBITDA | -48.99M |
| EBIT | -49.58M |
| Loss Per Share | -0.98 |
Balance Sheet
The company has 147.33 million in cash and 117,000 in debt, giving a net cash position of 147.22 million.
| Cash & Cash Equivalents | 147.33M |
| Total Debt | 117,000 |
| Net Cash | 147.22M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 134.02M |
| Book Value Per Share | 2.84 |
| Working Capital | 170.54M |
Cash Flow
In the last 12 months, operating cash flow was -67.64 million and capital expenditures -211,000, giving a free cash flow of -67.85 million.
| Operating Cash Flow | -67.64M |
| Capital Expenditures | -211,000 |
| Free Cash Flow | -67.85M |
| FCF Per Share | n/a |
Margins
Gross margin is 72.70%, with operating and profit margins of -114.62% and -104.74%.
| Gross Margin | 72.70% |
| Operating Margin | -114.62% |
| Pretax Margin | -102.79% |
| Profit Margin | -104.74% |
| EBITDA Margin | -113.25% |
| EBIT Margin | -114.62% |
| FCF Margin | n/a |
Dividends & Yields
SLNCF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.69% |
| Shareholder Yield | -24.69% |
| Earnings Yield | -30.56% |
| FCF Yield | -45.76% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SLNCF has an Altman Z-Score of 4.35.
| Altman Z-Score | 4.35 |
| Piotroski F-Score | n/a |